Savvy Updates, 10/11/21: Omnipod 5 Impressive, (2) Medtronic Pump Recalls, Mannkind’s Afrezza Trial for Peds, Non-Invasive CGMs: GraphWear & KnowU, Medicare Drug Pricing under Review, Kidney Disease Research

Savvy Updates, 10/11/21: Omnipod 5 Impressive, (2) Medtronic Pump Recalls, Mannkind’s Afrezza Trial for Peds, Non-Invasive CGMs: GraphWear & KnowU, Medicare Drug Pricing under Review, Kidney Disease Research type 2 diabetes can be reversed FDA Approval of Omnipod 5 Looks Read more

Savvy Updates, 9/13/21: Dexcom Follow App Research, Non-invasive BG Monitoring, FDA & Dietary Supplements, Melatonin & Sleep, diaTribe Musings

Savvy Updates, 9/13/21: Dexcom Follow App Research, Non-invasive BG Monitoring, FDA & Dietary Supplements, Melatonin & Sleep, diaTribe Musings type 2 diabetes can be reversed PARTICIPANTS NEEDED FOR RESEARCH SURVEY from the University of Utah College of Nursing  T1Ds over Read more

Savvy Updates, 8/16/21: GWave Non-Invasive CGM, Pancreatic Beta Cell Boost, Kidney Disease “Treasury Map”

Savvy Updates, 8/16/21: GWave Non-Invasive CGM, Pancreatic Beta Cell Boost, Kidney Disease “Treasury Map” type 2 diabetes can be reversed Diabetes startup brews up $ 11M after ‘serendipitous spill’ led to creation of new CGM tech was reported by Andrea Read more

Savvy Updates, 7/19/21: Non-invasive Saliva BG Test, Lilly’s $1B Purchase of Protomer for Smart Insulin, FDA Update on D Device Approvals, Dexcom’s FDA Approval for Web API Integration with Apps, GWave Non-invasive BG

Savvy Updates, 7/19/21: Non-invasive Saliva BG Test, Lilly’s B Purchase of Protomer for Smart Insulin, FDA Update on D Device Approvals, Dexcom’s FDA Approval for Web API Integration with Apps, GWave Non-invasive BG type 2 diabetes can be reversed Australian Read more